Sarah Hamby
Family · Anderson, SCNPI 1700395738
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 529 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,642 and has fallen 52.4% since, to $1,734 in 2025. Among family clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 529 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Supernus Pharmaceuticals, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$890
- Axsome Therapeutics, Inc.$822
- Otsuka America Pharmaceutical, Inc.$746
- Alkermes, Inc.$637
- plus $4K from 20 others
What the payments were for
- Food & beverage$9,683100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 105 | $1,473 |
| Supernus Pharmaceuticals, Inc. | 33 | $1,027 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 49 | $890 |
| Axsome Therapeutics, Inc. | 40 | $822 |
| Otsuka America Pharmaceutical, Inc. | 48 | $746 |
| Alkermes, Inc. | 28 | $637 |
| Corium, LLC | 43 | $575 |
| Lundbeck LLC | 30 | $531 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $489 |
| Almatica Pharma LLC | 23 | $393 |
| Bausch Health US, LLC | 18 | $363 |
| Vanda Pharmaceuticals Inc. | 13 | $331 |
| Teva Pharmaceuticals USA, Inc. | 17 | $290 |
| Neos Therapeutics, LP | 15 | $274 |
| Tris Pharma Inc | 10 | $204 |
| Johnson & Johnson | 8 | $177 |
| Sunovion Pharmaceuticals Inc. | 4 | $100 |
| Ironshore Pharmaceuticals Inc. | 6 | $88 |
| Idorsia Pharmaceuticals US Inc | 4 | $71 |
| Noven Therapeutics, LLC | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Dexcom, Inc. | 1 | $35 |
| Merck | 2 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $28 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Galderma Laboratories, L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,695 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 11 | $15,761 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 26 | $1,625 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 37 | $1,315 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $817 |
| Quetiapine Fumarate | 45 | $636 |
| Duloxetine Hcl | 40 | $617 |
| Bupropion XlBupropion Hcl | 42 | $524 |
| Vilazodone Hcl | 13 | $443 |
| Trazodone Hcl | 36 | $344 |
| Mirtazapine | 25 | $167 |
| Buspirone Hcl | 13 | $164 |
| Prazosin Hcl | 13 | $127 |
| Escitalopram Oxalate | 16 | $113 |
| Memantine Hcl | 19 | $112 |
| Lamotrigine | 15 | $109 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,473 | $15,76111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,248 family providers in South Carolina.
Other family in Anderson
- Kara Cooper GilmerAnderson$127K
- Nancy RichmondAnderson$21K
- Margaret KelleyAnderson$12K
- Lisa CobbAnderson$11K
- Sara ChristieGreenville$229K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.